Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Eric R. Weiss"'
Publikováno v:
mBio, Vol 10, Iss 3 (2019)
ABSTRACT It has recently emerged that HIV-1 Nef counteracts the antiviral host proteins SERINC3 and SERINC5. In particular, SERINC5 inhibits the infectivity of progeny virions when incorporated. SERINC3 and SERINC5 are also counteracted by the unrela
Externí odkaz:
https://doaj.org/article/4570759b8a0d412fab429d4bc1dbaa0d
Publikováno v:
Biotechnology progressREFERENCES. 37(2)
Ongoing efforts in the biopharmaceutical industry to enhance productivity and reduce manufacturing costs include development of intensified, linked, and/or continuous processes. One approach to improve productivity and process economics of the polish
Autor:
Eric R Weiss, Elena Popova, Hikaru Yamanaka, Hyung Cheol Kim, Jon M Huibregtse, Heinrich Göttlinger
Publikováno v:
PLoS Pathogens, Vol 6, Iss 9, p e1001107 (2010)
Retroviruses engage the ESCRT pathway through late assembly (L) domains in Gag to promote virus release. HIV-1 uses a PTAP motif as its primary L domain, which interacts with the ESCRT-I component Tsg101. In contrast, certain other retroviruses prima
Externí odkaz:
https://doaj.org/article/0d0e45f261764a47ab89d8ff1e1d8041
Autor:
Eric R. Weiss, Balaji Olety, Yuanfei Wu, Heinrich G. Göttlinger, Elena Popova, Hikaru Yamanaka
Publikováno v:
mBio
mBio, Vol 10, Iss 3 (2019)
mBio, Vol 10, Iss 3, p e01071-19 (2019)
mBio, Vol 10, Iss 3 (2019)
mBio, Vol 10, Iss 3, p e01071-19 (2019)
The Nef protein of HIV-1 and the unrelated glycoGag protein of a murine leukemia virus similarly prevent the uptake of antiviral host proteins called SERINC3 and SERINC5 into HIV-1 particles, which enhances their infectiousness. We now show that alth
Autor:
Juerg R. Straubhaar, Robin M. Brody, Larisa Kamga, Eric R. Weiss, Mohan Somasundaran, Linda K. Lambrecht, Margaret M. McManus, Katherine Luzuriaga, Thomas C. Greenough
Publikováno v:
The Journal of Immunology. 195:4185-4197
Virus-specific CD8+ T cells expand dramatically during acute EBV infection, and their persistence is important for lifelong control of EBV-related disease. To better define the generation and maintenance of these effective CD8+ T cell responses, we u
Autor:
Alexandre Melnikov, Susanna L. Lamers, Liisa K. Selin, Katherine Luzuriaga, Mohan Somasundaran, Chad Nusbaum, Eric R. Weiss, Manuel Garber, Jennifer L. Henderson
Publikováno v:
Journal of virology. 92(2)
Over 90% of the world's population is persistently infected with Epstein-Barr virus. While EBV does not cause disease in most individuals, it is the common cause of acute infectious mononucleosis (AIM) and has been associated with several cancers and
Autor:
Mohan Somasundaran, Yasin Bakis, Javier Gordon Ogembo, Eric R. Weiss, Galit Alter, Jennifer L. Henderson, Manuel Garber, Katherine Luzuriaga, Barbara Tabak, Liisa K. Selin
Publikováno v:
Journal of Virology. 91
The Epstein-Barr virus (EBV) gp350 glycoprotein interacts with the cellular receptor to mediate viral entry and is thought to be the major target for neutralizing antibodies. To better understand the role of EBV-specific antibodies in the control of
Autor:
Eric R. Weiss, Frank E. Brewster, James A. Coderre, Barbara Tabak, Timothy F. Kowalik, Mohan Somasundaran, Margaret M. McManus, Katherine Luzuriaga, Nicholas Renzette, Manuel Garber, Thomas C. Greenough
Publikováno v:
Journal of Virology. 88:3744-3755
We report the diversity of latent membrane protein 1 (LMP1) gene founder sequences and the level of Epstein-Barr virus (EBV) genome variability over time and across anatomic compartments by using virus genomes amplified directly from oropharyngeal wa